When cells are exposed to ionizing radiation, they initiate a complex respo
nse that includes the arrest of cell cycle progression in G1 and G2, apopto
sis and DNA repair. DNA is an important subcellular target of ionizing radi
ation, but oxydative damage to plasma membrane lipid initiates signal trans
duction pathways that activate apoptosis and that may play a role in cell c
ycle regulation. How is DNA damage converted into intracellular signals for
cell cycle arrest! The ataxia telangectasia mutant (ATM) protein and/or th
e DNA-dependent protein kinase (DNA-PK), that are bath activated by DNA dam
age, may initiate cell cycle arrest by activating the p53 tumor suppressor
protein. The p53 protein acts as a transcription factor and regulates expre
ssion of several components implicated in pathways that regulate cell cycle
progression. The best known, p21(WAF1/CIP1) protein, is an inhibitor of cy
clin-dependent kinases (CDK), a family of protein kinases known as key regu
lators of cell cycle progression. p21(WAF1/CIP1) was shown to be able to in
hibit several CDK; but is most effective toward G1/S cyclins. Other CDK inh
ibitors, p27(KIP1) and p15(INK4b) are activated by irradiation and contribu
te td the GI arrest. Moreover, radiation-induced G2 arrest was shown to req
uire inhibitory phospharylation of the kinase cdc2 via an ATM-dependent pat
hway. Mutations in cell cycle regulatory genes are common in human cancer a
nd cell cycle regulatory deficiency can lead to increase resistance to ioni
zing radiation in cancer cells. The major function of p53-dependent G1 arre
st may be elimination of cells containing DNA damage whereas G2 arrest foll
owing radiation has been shown to be important in protecting cells from dea
th. Cell cycle checkpoints offer a new set of potential targets for chemoth
erapeutic compounds, especially the G2 checkpoint. Thus, abrogation of the
G2 checkpoint with methylxanthines such as caffeine or protein Kinase inhib
itors such as staurosporine and UCN-01 (7-hydroxystaurasporine) was found t
o sensitize cells to ionizing radiation. These data did not lead to clinica
l applications, but confirm targeting of the G2 checkpoint may be an import
ant strategy for cancer therapy.